TABLE 3

Analysis of serum glucose and lipids and dual-emission X-ray absorptiometry analysis of a separate cohort for adiposity: all measurements taken at 24 weeks

RCSnPGTotal cholesterolTriglyceridesCarcass fat (g)Percentage of fatn
116280 ± 26113 ± 4*325 ± 15*12.2 ± 1.4§28.6 ± 2.2§6
216146 ± 6*98 ± 3*245 ± 11§11.8 ± 1.230.6 ± 2.0§6
319184 ± 12§108 ± 6*280 ± 1713.7 ± 0.630.4 ± 0.6§3
411166 ± 11§182 ± 11421 ± 26*16.8 ± 0.6§38.6 ± 0.9§5
516148 ± 993 ± 2*265 ± 1415.9 ± .735.4 ± 0.98
619217 ± 21211 ± 11380 ± 17*7.4 ± 1.623.2 ± 4.0§6
711257 ± 22172 ± 12269 ± 1017.5 ± 2.037.9 ± 2.23
817261 ± 24155 ± 5282 ± 1714.4 ± 0.732.0 ± 0.8§4
914176 ± 13§123 ± 6250 ± 15§12.2 ± 0.228.3 ± 0.4§4
105460 ± 36*§170 ± 20300 ± 19§14.6 ± 1.2§31.3 ± 1.5§2
F17375 ± 30*§169 ± 19144 ± 3320.2 ± 0.7*33.8 ± 0.8§7
NZO9260 ± 40194 ± 2*177 ± 2021.1 ± 1.0*38.2 ± 1.1§3
NON9189 ± 10152 ± 14198 ± 1913.1 ± 1.132.4 ± 1.4§5
  • Data are means ± SEM unless otherwise indicated.

  • *

    * Significantly different from NON/Lt (P < 0.0023);

  • suggestive significant difference from NON/Lt (P < 0.05);

  • significantly different from NZO/HlLt (P < 0.0023);

  • §

    § suggestive significant difference from NZO/HlLt (P < 0.05).